Document is current
Any future updates will be listed below
-
Authors
Quintela-Fandino, Miguel
Apala, Juan V.
Malon, Diego
Mouron, Silvana
Hornedo, Javier
Gonzalez-Cortijo, Lucia
Colomer, Ramon
Guerra, Juan
-
Funding
Funding for this research was provided by:
Instituto de Salud Carlos III (PI16/00354, PI17/01865, PIE15/00068)
Comunidad de Madrid (B2017/BMD3733)
- License Information
-
More Information
Article History
Received: 26 November 2018
Accepted: 6 May 2019
First Online: 24 May 2019
Ethics approval and consent to participate
: Institutional review board approval was obtained from all participating hospitals (the names of the ethics committees were Comité Ético del Hospital La Princesa, Comité Ético del Hospital de Fuenlabrada, Comité Ético Quiron FJD-Pozuelo). All patients provided written informed consent. The study (CNIO-BR-007) was registered at (NCT02619162).
: Informed consent form included the permission for trial data publication.
: MQF received research funds from the following companies: Novartis, Roche, Bayer, Boehringer-Ingelheim, Astra Zeneca, and MEI Pharma.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
